ALOX5 and tauopathy: The elucidation of the role of this enzyme in tauopathy pathogenesis provides a strong biological support for the hypothesis that pharmacologic inhibition of 5LO represents a novel and viable therapeutic strategy for treating or halting the clinical and pathological symptoms of human tauopathies.